| 17alpha-ethynylestradiol | affects expression | ISO | RGD:1314002 | 6480464 | Ethinyl Estradiol affects the expression of PINK1 mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1314002 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of PINK1 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:1314002 | 6480464 | Ethinyl Estradiol results in decreased expression of PINK1 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1314001 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PINK1 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1314001 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PINK1 mRNA | CTD | PMID:20106945 PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PINK1 mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1314002 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of PINK1 mRNA | CTD | PMID:17942748 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of PINK1 mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of PINK1 mRNA | CTD | PMID:21346803 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1314002 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of PINK1 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1314002 | 6480464 | Benzo(a)pyrene results in decreased expression of PINK1 mRNA | CTD | PMID:20127859 |
| cadmium dichloride | increases expression | ISO | RGD:1314002 | 6480464 | Cadmium Chloride results in increased expression of PINK1 mRNA | CTD | PMID:20883709 |
| calcitriol | increases expression | ISO | RGD:1314001 | 6480464 | Calcitriol results in increased expression of PINK1 mRNA | CTD | PMID:16002434 |
| cisplatin | multiple interactions | ISO | RGD:1314001 | 6480464 | [Piroxicam co-treated with Cisplatin] results in increased expression of PINK1 mRNA | CTD | PMID:21858171 |
| clofibric acid | affects expression | EXP | | 6480464 | Clofibric Acid affects the expression of PINK1 mRNA | CTD | PMID:17602206 |
| copper atom | decreases expression | EXP | | 6480464 | Copper results in decreased expression of PINK1 mRNA | CTD | PMID:22465980 |
| copper(0) | decreases expression | EXP | | 6480464 | Copper results in decreased expression of PINK1 mRNA | CTD | PMID:22465980 |
| coumestrol | decreases expression | ISO | RGD:1314001 | 6480464 | Coumestrol results in decreased expression of PINK1 mRNA | CTD | PMID:19167446 |
| Delta(9)-tetrahydrocannabinol | decreases expression | ISO | RGD:1314002 | 6480464 | Tetrahydrocannabinol results in decreased expression of PINK1 mRNA | CTD | PMID:12237329 |
| diazinon | decreases expression | EXP | | 6480464 | Diazinon results in decreased expression of PINK1 mRNA | CTD | PMID:21968025 |
| dopamine | multiple interactions | ISO | RGD:1314002 | 6480464 | [PINK1 mutant form results in increased susceptibility to Paraquat] which results in decreased abundance of Dopamine; more ... | CTD | PMID:22043175 |
| dopamine | affects abundance | ISO | RGD:1314002 | 6480464 | PINK1 protein affects the abundance of Dopamine | CTD | PMID:22043175 |
| hydrogen peroxide | multiple interactions | ISO | RGD:1314001 | 6480464 | HMOX1 protein affects the reaction [PINK1 protein affects the susceptibility to Hydrogen Peroxide]; more ... | CTD | PMID:21366594 |
| hydrogen peroxide | multiple interactions | ISO | RGD:1314002 | 6480464 | PINK1 protein affects the reaction [Hydrogen Peroxide results in increased chemical synthesis of Reactive Oxygen Species] | CTD | PMID:21421046 |
| hydrogen peroxide | affects response to substance | ISO | RGD:1314001 | 6480464 | PINK1 protein affects the susceptibility to Hydrogen Peroxide | CTD | PMID:21366594 |
| N-ethyl-N-nitrosourea | increases mutagenesis | EXP | | 6480464 | Ethylnitrosourea results in increased mutagenesis of PINK1 gene | CTD | PMID:16495775 |
| N-methyl-4-phenylpyridinium | affects response to substance | ISO | RGD:1314001 | 6480464 | PINK1 protein affects the susceptibility to 1-Methyl-4-phenylpyridinium | CTD | PMID:16226715 |
| N-methyl-4-phenylpyridinium | multiple interactions | ISO | RGD:1314001 | 6480464 | PINK1 protein affects the reaction [1-Methyl-4-phenylpyridinium results in increased expression of HMOX1 mRNA]; more ... | CTD | PMID:21366594 |
| ochratoxin A | increases expression | EXP | | 6480464 | ochratoxin A results in increased expression of PINK1 mRNA | CTD | PMID:19717638 |
| paracetamol | affects expression | ISO | RGD:1314002 | 6480464 | Acetaminophen affects the expression of PINK1 mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:1314001 | 6480464 | Acetaminophen results in increased expression of PINK1 mRNA | CTD | PMID:22230336 |
| paraquat | decreases expression | ISO | RGD:1314002 | 6480464 | Paraquat results in decreased expression of PINK1 mRNA | CTD | PMID:22563483 |
| paraquat | multiple interactions | ISO | RGD:1314002 | 6480464 | [PINK1 mutant form results in increased susceptibility to Paraquat] which results in decreased abundance of Dopamine; more ... | CTD | PMID:22043175 |
| paraquat | increases response to substance | ISO | RGD:1314002 | 6480464 | PINK1 mutant form results in increased susceptibility to Paraquat | CTD | PMID:22043175 |
| phlorizin | increases expression | ISO | RGD:1314002 | 6480464 | Phlorhizin results in increased expression of PINK1 mRNA | CTD | PMID:22538082 |
| pirinixic acid | multiple interactions | ISO | RGD:1314002 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PINK1 mRNA | CTD | PMID:19710929 |
| piroxicam | multiple interactions | ISO | RGD:1314001 | 6480464 | [Piroxicam co-treated with Cisplatin] results in increased expression of PINK1 mRNA | CTD | PMID:21858171 |
| resveratrol | increases expression | ISO | RGD:1314002 | 6480464 | resveratrol results in increased expression of PINK1 mRNA | CTD | PMID:22610192 |
| rotenone | decreases response to substance | ISO | RGD:1314001 | 6480464 | PINK1 protein results in decreased susceptibility to Rotenone | CTD | PMID:19492085 |
| rotenone | affects response to substance | ISO | RGD:1314002 | 6480464 | PINK1 protein affects the susceptibility to Rotenone | CTD | PMID:21421046 |
| rotenone | affects response to substance | ISO | RGD:1314001 | 6480464 | PINK1 protein affects the susceptibility to Rotenone | CTD | PMID:16226715 PMID:20940149 |
| rotenone | increases expression | ISO | RGD:1314002 | 6480464 | Rotenone results in increased expression of PINK1 protein | CTD | PMID:20464527 |
| rotenone | affects response to substance | ISO | RGD:1314001 | 6480464 | PINK1 protein affects the susceptibility to Rotenone | CTD | PMID:16226715 |
| superoxide | affects abundance | ISO | RGD:1314002 | 6480464 | PINK1 protein affects the abundance of Superoxides | CTD | PMID:21421046 |
| tacrolimus hydrate | multiple interactions | ISO | RGD:1314001 | 6480464 | PINK1 protein affects the reaction [Tacrolimus results in increased phosphorylation of DNM1L protein] | CTD | PMID:19492085 |
| tamoxifen | affects expression | ISO | RGD:1314002 | 6480464 | Tamoxifen affects the expression of PINK1 mRNA | CTD | PMID:17555576 |
| trans-resveratrol | increases expression | ISO | RGD:1314002 | 6480464 | resveratrol results in increased expression of PINK1 mRNA | CTD | PMID:22610192 |
| tunicamycin | decreases expression | ISO | RGD:1314002 | 6480464 | Tunicamycin results in decreased expression of PINK1 mRNA | CTD | PMID:17127020 |
| valproic acid | affects expression | ISO | RGD:1314002 | 6480464 | Valproic Acid affects the expression of PINK1 mRNA | CTD | PMID:17292431 |
| vancomycin | increases expression | ISO | RGD:1314002 | 6480464 | Vancomycin results in increased expression of PINK1 mRNA | CTD | PMID:18930951 |